Special Issue: Innovations & Insights in Lymphoma
Aims & Scope
Lymphoma is one of the most common cancers, with over 500,000 new cases per year for Non-Hodgkin Lymphoma alone.
Progress in the early detection of Lymphoma is allowing patients more treatment options than in the past. New drugs, targeted therapies, and gene therapy have the potential to revolutionize the way we treat Lymphoma.
This Special Issue will focus on recent developments in our understanding of Lymphoma and possible paths towards reducing the burden of the disease.